EZH2 and pachyonychia congenita: Despite the equivocal relations between HNF1B, EZH2 and ECI2, the high expression of EZH2 and ECI2 in PC seems to be a potential therapeutic target, especially in the case of EZH2 as suggested in previous studies17,58–63.